)
Edge31 Oct 2025
Rolls-Royce: Full Thrust Ahead
From century-old crafted perfection to pandemic shock and reset, Rolls-Royce's story is shaped by heritage, turbulence, and a disciplined climb back.
Teva Pharmaceutical Industries (TEVA) investor relations material
Teva Pharmaceutical Industries Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary5 Nov, 2025
Executive summary
Achieved 11th consecutive quarter of revenue growth, with Q3 2025 revenues up 3% year-over-year to $4.5 billion, driven by innovative products and US generics, and an 8% CAGR from Q3 2023 to Q3 2025.
Innovative brands (AUSTEDO, UZEDY, AJOVY) delivered up to 38% year-over-year growth, with the innovative portfolio exceeding $800 million in quarterly revenue.
Transformation and cost-saving programs are on track, targeting $700 million in savings by 2027 and a 30% non-GAAP operating margin.
Net income attributable to shareholders was $433 million, compared to a net loss of $437 million in Q3 2024.
Free cash flow for Q3 was $515 million, down from $922 million in Q3 2024, mainly due to lower operating cash flow and divestiture proceeds.
Financial highlights
Adjusted EBITDA increased 5–6% year-over-year to $1.4 billion; non-GAAP EPS up 14% to $0.78.
Non-GAAP gross margin rose to 55.3%, and non-GAAP operating margin improved to 28.9%.
GAAP gross margin was 51.4%, with GAAP operating margin at 19.7%.
Net debt reduced to $14.6–$16.8 billion, with net debt/EBITDA at 2.95x.
YTD 2025 revenues reached $12.5 billion (+2% YoY), with YTD non-GAAP operating income up 7%.
Outlook and guidance
2025 revenue guidance narrowed to $16.8–$17.0 billion; AUSTEDO outlook raised to $2.05–$2.15 billion, AJOVY/UZEDY reaffirmed at $630–$640 million/$190–$200 million.
Non-GAAP operating income guidance raised to $4.4–$4.6 billion; adjusted EBITDA to $4.8–$5.0 billion.
Non-GAAP diluted EPS guidance increased to $2.55–$2.65.
Free cash flow guidance unchanged at $1.6–$1.9 billion for 2025.
2027 targets reaffirmed: mid-single-digit revenue growth, 30% operating margin, net debt/EBITDA of 2x.
Quantify IRA's impact on AUSTEDO 2027 target
TAPI sale termination: impact on divestment timeline?
Rationale for R&D shift to immunology from neuro?
AUSTEDO: How will IRA affect market share vs. Ingrezza?
TAPI: What changed to restart the sale process?
Biosimilars: How to maintain edge with lower entry barriers?
Austedo XR IRA impact on 2026 formulary?
TAPI divestment: What terms are critical?
Biosimilar FDA guidance impact on portfolio?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Teva Pharmaceutical Industries earnings date
UBS Global Healthcare Conference 202510 Nov, 2025
Next Teva Pharmaceutical Industries earnings date
UBS Global Healthcare Conference 202510 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates in two segments, Generic Medicines and Specialty Medicines. The company offers various APIs and molecules for the treatment of various disorders in a range of therapeutic areas, including CNS, oncology, respiratory, cardiology and other specialty areas. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage